Suchergebnisse - "Chuaypen, Natthaya"

PubPharm (6)

1

Predictive Role of Pretreatment Circulating miR-221 in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization

enthalten in: Diagnostics (Basel, Switzerland) | 2023

von Pinjaroen, N. | Chailapakul, P. | Sriphoosanaphan, S. | +2

2

Kinetics of serum HBsAg and intrahepatic cccDNA during pegylated interferon therapy in patients with HBeAg-positive and HBeAg-negative chronic hepatitis B

enthalten in: Journal of medical virology | 2017

von Chuaypen, N. | Sriprapun, M. | Praianantathavorn, K. | +4

3

Kinetics of serum HBsAg and intrahepatic cccDNA during pegylated interferon therapy in patients with HBeAg‐positive and HBeAg‐negative chronic hepatitis B

enthalten in: Journal of medical virology | 2017

von Chuaypen, N. | Sriprapun, M. | Praianantathavorn, K. | +4

4

Original Research : Analysis of hepatic microRNA alterations in response to hepatitis B virus infection and pegylated interferon alpha-2a treatment

enthalten in: Experimental biology and medicine (Maywood, N.J.) | 2016

von Jinato, T. | Chuaypen, N. | Poomipak, W. | +6

5

Serum hepatitis B core-related antigen as a treatment predictor of pegylated interferon in patients with HBeAg-positive chronic hepatitis B

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2016

von Chuaypen, N. | Posuwan, N. | Payungporn, S. | +4

6

Serum hepatitis B core‐related antigen as a treatment predictor of pegylated interferon in patients with HBeAg‐positive chronic hepatitis B

enthalten in: Liver international | 2016

von Chuaypen, N. | Posuwan, N. | Payungporn, S. | +4

1
[1]